Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,322,381
+$3,588,274 QoQ
Shares Held
290,523
+171.1% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Derivatives in ERAS
reported options exposure · as of Jun 30, 2026CallValue
$2,315,648
CallShares
126,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. ERAS ranks #57 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ERAS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,322,381 | 290,523 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $2,315,648 | 126,400 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,734,107 | 107,176 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $818,891 | 220,132 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $345,750 | 158,601 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $173,857 | 136,896 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $186,067 | 135,816 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $334,776 | 133,377 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $564,123 | 206,639 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $173,124 | 73,358 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $107,851 | 52,355 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $103,717 | 48,694 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $66,160 | 33,584 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $116,734 | 42,295 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $73,618 | 24,458 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $43,531 | 10,100 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,154 | 789 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,458 | 621 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $240,464 | 27,961 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $391,572 | 25,133 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,419 | 114 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||